Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment

MeSH terms

• Antibodies, Monoclonal, Humanized / pharmacology*
• Antibodies, Monoclonal, Humanized / therapeutic use
• Antineoplastic Agents, Immunological / pharmacology*
• Antineoplastic Agents, Immunological / therapeutic use
• Biomarkers, Tumor / genetics
• Drug Resistance, Neoplasm / genetics
• Drug Resistance, Neoplasm / immunology
• Female
• Health Status Disparities*
• Humans
• Inflammation / immunology*
• Male
• Mutation Rate
• Neoplasms / drug therapy*
• Neoplasms / genetics
• Neoplasms / immunology
• Predictive Value of Tests
• Prognosis
• Sex Factors
• T-Lymphocytes / immunology
• Treatment Outcome
• Tumor Microenvironment / immunology